Affiliation:
1. Hybridon, Inc., Worcester, Massachusetts 01605.
Abstract
In the past 4 years, interest in drug-resistant herpesviruses has evolved from the realm of academic laboratory studies to that of great clinical importance. Recurrent and persistent infections due to the herpes simplex viruses, varicella-zoster virus, and human cytomegalovirus have been an unwelcome consequence of immunosuppression in graft recipients, cancer patients, and those suffering from AIDS. Treatment of these infections with the available antiviral drugs, such as acyclovir, ganciclovir, and foscarnet, has resulted in both clinical benefit and the emergence of drug-resistant variants. In addition, the role of Epstein-Barr virus is being clarified for an array of disease syndromes, and therapeutic approaches are beginning to emerge. In the present review, the emergence and clinical importance of drug resistance among the herpesviruses have been explored. Furthermore, particular attention has been focused on our understanding of the mechanisms of drug resistance and how that understanding will guide us in the development of more effective antiviral drugs and drug usage.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology
Reference147 articles.
1. Severe and recurrent varicella-zoster virus infection in a patient with the acquired immune deficiency syndrome;Acheson D. W. K.;J. Infect.,1988
2. Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome;Alessi E.;Arch. Dermatol.,1988
3. Balfour H. H. Jr. 1988. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am. J. Med. 85(Suppl. 2A):68-73.
4. Varicella zoster virus infections in the immunocompromised host. Natural history and treatment;Balfour H. H.;Scand. J. Infect. Dis. Suppl.,1991
5. A randomized, placebocontrolled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts;Balfour H. H.;N. Engl. J. Med.,1989
Cited by
139 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献